RankingsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Cash from investing

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥189.3B
P/E ratio
67.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-19,650+235.67%
Mar 31, 2024-5,854+122.84%
Mar 31, 2023-2,627-66.70%
Mar 31, 2022-7,888+379.81%
Mar 31, 2021-1,644-34.97%
Mar 31, 2020-2,528-55.99%
Mar 31, 2019-5,744+77.01%
Mar 31, 2018-3,245-7.37%
Mar 31, 2017-3,503-14.67%
Mar 31, 2016-4,105-967.86%
Mar 31, 2015473

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)